Sharon M Hertz from Charlo, MT, age 53

Youtube

Hertz To Pay $168 Million To Customers For Th...

Hertz falsely accused paying customers of stealing their rental cars a...

Duration:

6m 41s

Propoxyphene Action

Sharon Hertz, M.D advises consumers on the known effects of the pain k...

Duration:

1m 35s

Sharon Mann | Hertz

The Voice of Sharon Mann for Hertz : Love the Road I'm Sharon Mann, an...

Duration:

1m 1s

CLE woman shares rental car nightmare after r...

Sharon McCue of Cleveland lived through what she called a rental car n...

Duration:

4m 28s

An Rx to Reverse Muscle Relaxants During Surg...

... help patients recover sooner from medications used for intubation ...

Duration:

55s

Opioid Pain Rx Approved for Kids

... around-the-clock... long-term opioid treatment for which alternat...

Duration:

43s

Classmates

Sharon Klassen (Hertz)

view source

Schools:

Medicine Hat High School Medicine Hat Azores 1985-1989

Community:

Linda Foster, Margo Giesinger

Medicine Hat High School,...

view source

Graduates:

Richard Keating (1964-1968),
Sharon Hertz (1985-1989),
Laurie Hammel (1978-1982),
Robert Chamberlain (1971-1975)

Sharon Hertz, Class of 19...

view source

Sharon Hertz | Class of 1...

view source

Sussex County Vo-Tech Hig...

view source

Graduates:

Sharon Hertz (1994-1998),
Michael Rota (1982-1986),
Richard Pittenger (1967-1971),
Earl Hotalen (1980-1984),
Michael Adams (1969-1973),
Phil Eberle (1971-1975)

News

FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

view source

Todays approval represents the first FDA-approved non-opioid treatment for the management of opioid withdrawal symptoms and provides a new option that allows providers to work with patients to select the treatment best suited to an individuals needs, said Sharon Hertz, M.D., director of the Divi
Date: May 16, 2018
Category: Health
Source: Google

FDA Joint Panel Votes Down Opana ER

view source

to have originated from the FDA's Office of Surveillance and Epidemiology, with a letter from Judy Staffa, PhD, RPh, leading the FDA's meeting materials. Staffa presided over the meeting. Sharon Hertz, MD, director of FDA's division of anesthesia, analgesia, and addiction products, was in attendance.
Date: Mar 14, 2017
Category: Health
Source: Google

FDA Science Advisors Talk Strategy on Opioids

view source

During a scheduled talk, Sharon Hertz, MD, director of the FDA's anesthesia, analgesia, and addiction products at its Center for Drug Evaluation and Research (CDER), described the two public-private partnership organizations that developed enriched enrollment -- ACTTION and IMMPACT -- as key com
Date: Mar 02, 2016
Category: Health
Source: Google

FDA approves Bridion to reverse effects of neuromuscular blocking drugs used ...

view source

"Bridion provides a new treatment option that may help patients recover sooner from medications used for intubation or ventilation during surgery, said Sharon Hertz, M.D., director of the Division of Anesthesia, Analgesia and Addiction Products in the FDAs Center for Drug Evaluation and Research.
Date: Dec 15, 2015
Category: Health
Source: Google

FDA Approves New Anti-Abuse Label for Embeda

view source

olving and these properties will not completely fix the problem. But they can be part of a comprehensive approach to combat the very serious problem of prescription drug abuse in the U.S., said Sharon Hertz, MD, acting director of the FDAs Division of Anesthesia, Analgesia, and Addiction Products.
Date: Oct 18, 2014
Category: Health
Source: Google

FDA approves hard-to-abuse narcotic painkiller

view source

harder to abuse is needed in order to help address the public health crisis of prescription drug abuse in the U.S.," Dr. Sharon Hertz, deputy director of the division of anesthesia, analgesia and addiction products in the FDA's Center for Drug Evaluation and Research, said in an agency news release.
Date: Jul 24, 2014
Category: Health
Source: Google

New abuse-deterrent painkiller approved

view source

's approval, "...will better enable the FDA to balance addressing this problem with meeting the needs of the millions of people in this country suffering from pain," said Dr. Sharon Hertz, deputy director of the Division of Anesthesia, Analgesia and Addiction Products at the FDA, in a press release.
Date: Jul 24, 2014
Category: Health
Source: Google

Purdue earns a nod--and a quick slap--for abuse-resistant painkiller

view source

S.," said Sharon Hertz, deputy director of the Division of Anesthesia, Analgesia and Addiction Products in the FDA's Center for Drug Evaluation and Research, in a statement. "Encouraging the development of opioids with abuse-deterrent properties is just one component of a broader approach to reducin
Date: Jul 24, 2014
Category: Health
Source: Google